Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.51
Delayed Data
As of 10:04am ET
 +0.51 / +8.50%
Today’s Change
4.76
Today|||52-Week Range
8.24
+9.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$30.3M

Company Description

ImmuCell Corp. operates as a biotechnology company, which engages in the development, manufacture, and sale of products to improve animal health and productivity in the dairy and beef industry. Its products focus on prevention, diagnosis, and treatment of bovine diseases. The company was founded by Frank E. Ruch in 1982 and is headquartered in Portland, ME.

Contact Information

ImmuCell Corp.
56 Evergreen Drive
Portland Maine 04103
P:(207) 878-2770
Investor Relations:

Employees

Shareholders

Other institutional4.65%
Individual stakeholders30.37%
Mutual fund holders11.53%

Top Executives

Michael F. BrighamPresident, CEO, Secretary, Treasurer & Director
Joseph H. CrabbDirector & Chief Scientific Officer
Bobbi Jo BrockmannDirector & Vice President-Sales & Marketing
Elizabeth L. WilliamsVice President-Manufacturing Operations